These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29452525)

  • 21. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Building a more connected DSMB: better integrating ethics review and safety monitoring.
    Eckstein L
    Account Res; 2015; 22(2):81-105. PubMed ID: 25397600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective boards: working smarter to meet the challenge.
    Kazemek EA; Knecht PR; Westfall BG
    Trustee; 2000 May; 53(5):18-23, 1. PubMed ID: 11785220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving the process of research ethics review.
    Page SA; Nyeboer J
    Res Integr Peer Rev; 2017; 2():14. PubMed ID: 29451537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions that address institutional child maltreatment: An evidence and gap map.
    Finch M; Featherston R; Chakraborty S; Bjørndal L; Mildon R; Albers B; Fiennes C; Taylor DJA; Schachtman R; Yang T; Shlonsky A
    Campbell Syst Rev; 2021 Mar; 17(1):e1139. PubMed ID: 37133265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
    Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Development and Implementation of an Institutional Guideline for Prospective EEG Monitoring and Reporting of Delayed Cerebral Ischemia.
    Muniz CF; Shenoy AV; OʼConnor KL; Bechek SC; Boyle EJ; Guanci MM; Tehan TM; Zafar SF; Cole AJ; Patel AB; Westover MB; Rosenthal ES
    J Clin Neurophysiol; 2016 Jun; 33(3):217-26. PubMed ID: 27258445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of factors influencing the organizational capacity of Institutional Review Boards In China: a crisp-set Qualitative Comparative Analysis based on 107 cases.
    Lu L; Shi S; Liu B; Liu C
    BMC Med Ethics; 2023 Sep; 24(1):74. PubMed ID: 37749525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital governing boards and quality of care: a call to responsibility.
    National Quality Forum
    Trustee; 2005 Mar; 58(3):15-8. PubMed ID: 15825939
    [No Abstract]   [Full Text] [Related]  

  • 30. The institutional review board and protecting human subjects: 10 frequently asked questions.
    Zink S; Kimberly L; Wertlieb S
    Prog Transplant; 2005 Sep; 15(3):291-5. PubMed ID: 16252638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A realist review of which advocacy interventions work for which abused women under what circumstances.
    Rivas C; Vigurs C; Cameron J; Yeo L
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD013135. PubMed ID: 31254283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exposing exposure: enhancing patient safety through automated data mining of nuclear medicine reports for quality assurance and organ dose monitoring.
    Ikuta I; Sodickson A; Wasser EJ; Warden GI; Gerbaudo VH; Khorasani R
    Radiology; 2012 Aug; 264(2):406-13. PubMed ID: 22627599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitations of provider interventions in hypertension quality assurance.
    Winickoff RN; Wilner S; Neisuler R; Barnett GO
    Am J Public Health; 1985 Jan; 75(1):43-6. PubMed ID: 3966597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive genomic studies: emerging regulatory, strategic, and quality assurance challenges for biorepositories.
    McDonald SA; Mardis ER; Ota D; Watson MA; Pfeifer JD; Green JM
    Am J Clin Pathol; 2012 Jul; 138(1):31-41. PubMed ID: 22706855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How research ethics boards should monitor clinical research.
    Apau Bediako R; Kaposy C
    Account Res; 2020 Jan; 27(1):49-56. PubMed ID: 31847591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing and Implementing a Quality Assurance Strategy for Electroconvulsive Therapy.
    Hollingsworth J; Baliko B; McKinney S; Rosenquist P
    J ECT; 2019 Mar; 35(1):21-26. PubMed ID: 29668495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic approach to develop a core set of parameters for boards of directors to govern quality of care in the ICU.
    Oerlemans AJM; de Jonge E; van der Hoeven JG; Zegers M
    Int J Qual Health Care; 2018 Aug; 30(7):545-550. PubMed ID: 29635336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic protocols review by Institutional Review Boards at National Cancer Institute-designated cancer centers.
    Allen HJ
    Genet Test; 1998; 2(4):329-36. PubMed ID: 10464612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Institutional review boards: Challenges and opportunities.
    Ghooi RB
    Perspect Clin Res; 2014 Apr; 5(2):60-5. PubMed ID: 24741481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.